Zoetis Inc (ZTS) reported quarterly earnings results on Wednesday, Aug-3-2016. The company said it had a profit of $0.49 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.05. Analysts had a consensus of $0.44. The company posted revenue of $1208.00 million in the period, compared to analysts expectations of $1169.42 million. The company’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 EPS.
Many Wall Street Analysts have commented on Zoetis Inc. Zoetis Inc was Downgraded by Citigroup to ” Neutral” on Jun 10, 2016. Stifel Initiated Zoetis Inc on Jun 1, 2016 to “Buy”, Price Target of the shares are set at $58.Zoetis Inc was Downgraded by Goldman to ” Sell” on May 6, 2016.
Zoetis Inc closed down -0.68 points or -1.35% at $49.72 with 55,00,497 shares getting traded on Tusday. Post opening the session at $50.22, the shares hit an intraday low of $49.29 and an intraday high of $50.25 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.
Zoetis Inc. is engaged in the discovery development manufacture and commercialization of animal health medicines and vaccines with a focus on both livestock and companion animals. The Company markets products across four regions: the United States Europe/Africa/Middle East Canada/Latin America and Asia/Pacific; eight species: the livestock species of cattle swine poultry sheep and fish and the companion animal species of dogs cats and horses and five product categories: anti-infectives vaccines parasiticides medicated feed additives and other pharmaceutical products. In addition its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.